v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net income (loss) from continuing operations $ 35,683 $ (8,514) $ 33,066 $ (16,506)  
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Stock–based compensation     3,722 3,451  
Depreciation, depletion, and amortization     14,315  
Unrealized gain on derivatives (23,206) (23,090)  
Loss on adjustment to fair value – embedded derivatives, debt, and warrants 2,373 4,537  
Amortization and expensing of deferred financing costs     2,940  
Accretion of asset retirement obligation     71  
Changes in operating assets and liabilities:          
Accounts receivable     (42,546)  
Prepaid expenses and other current assets     (342) (78)  
Inventory     (3,410)  
Accounts payable and accrued expenses     16,401 5,844  
Ad valorem and production taxes payable     1,319  
Oil, natural gas, and NGL revenue payable     2,676  
Other assets and liabilities     63 (1,619)  
Net cash provided by (used in) continuing operating activities     9,722 (8,908)  
Net cash provided by discontinued operations     460  
Net cash provided by (used in) operating activities     9,722 (8,448)  
Cash flows from investing activities:          
Cash paid for Bayswater asset purchase     (467,461)  
Deposit for Nickel Road asset purchase     (9,000)  
Transaction expenses paid related to Nickel Road asset purchase     (100)  
Development of oil and natural gas properties     (53,973) (3,927)  
Cash paid for leasehold property purchases     (950)  
Cash received from payment on note receivable related to sale of cryptocurrency miners     95 186  
Cash received from sale of cryptocurrency miners     1,000  
Net cash used in investing activities     (522,289) (11,841)  
Cash flows from financing activities:          
Proceeds from the issuance of Common Stock     43,817  
Financing costs associated with issuance of Common Stock     (3,311)  
Proceeds from the issuance of Series F Preferred Stock     148,250  
Financing costs associated with the issuance of Series F Preferred Stock     (11,059)  
Borrowings on the Credit Facility     359,000  
Debt issuance costs associated with the Credit Facility     (15,670)  
Payments of the Subordinated Note – related party     (3,214)  
Proceeds from option exercise     633  
Treasury stock repurchased     (418)  
Proceeds from the exercise of Series D and E Preferred Stock warrants     9,478  
Net cash provided by financing activities     518,028 9,478  
Net increase (decrease) in cash and cash equivalents     5,461 (10,811)  
Cash and cash equivalents, beginning of the period     5,192 13,037 $ 13,037
Cash and cash equivalents, end of the period $ 10,653 $ 2,226 $ 10,653 $ 2,226 $ 5,192